Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2414]

Study finds biomarker may boost ovarian cancer chemotherapy response

Study finds biomarker may boost ovarian cancer chemotherapy response

IMPAKT 2015: PI3 kinase and CDK4/6 inhibitors are highly active in ER-positive breast cancer

IMPAKT 2015: PI3 kinase and CDK4/6 inhibitors are highly active in ER-positive breast cancer

IMPAKT 2015: Constitutively activated STAT3 may be a predictive marker for resistance to trastuzumab in patients with HER2 positive breast cancer

IMPAKT 2015: Constitutively activated STAT3 may be a predictive marker for resistance to trastuzumab in patients...

Multiple types of resistance to new lung cancer drug identified

Multiple types of resistance to new lung cancer drug identified

Preventive Gynaecology Special Issue honours memory of deceased pioneer

Preventive Gynaecology Special Issue honours memory of deceased pioneer

'Spectral histopathology' facilitates prognosis regarding tumour aggressivenes'

'Spectral histopathology' facilitates prognosis regarding tumour aggressivenes'

Dutch and US cancer researchers reiterate benefits of exercise for prostate cancer survivors

Dutch and US cancer researchers reiterate benefits of exercise for prostate cancer survivors

New drug combination shows promise for breaking breast cancer resistance

New drug combination shows promise for breaking breast cancer resistance

AACR 2015: Evidence points to fallopian-tube origins of ovarian cancers

AACR 2015: Evidence points to fallopian-tube origins of ovarian cancers

AACR 2015: PARP inhibitor combo shows early promise for patients with and without BRCA mutations

AACR 2015: PARP inhibitor combo shows early promise for patients with and without BRCA mutations

More from ecancer